No Free Lunch For Obesity Drugs

Emily BurkeThe WEEKLY

NO FREE LUNCH FOR OBESITY A major lead in curing obesity came on the scene in the 1990s when researchers noticed that obese mice lacked a critical hormone dubbed leptin. Suddenly, the tantalizing prospect of tackling¬†obesity with leptin treatments sent both drug developers and casual dieters astir. As the saying goes, there’s no free lunch, and excitement waned in recent … Read More

200,000 Is The Magic Number

Emily BurkeThe WEEKLY

ALPHABET SOUP: NEW DRUG APPROVALS Acronyms abound in the world of new drug approvals. Check out our cheat sheet below for help with some of the most common: BLA: Biologic Licensing Application Planning on developing a biologic drug? Would you like to bring it to market? You will need to submit one of these to the FDA which gives them … Read More

The FDA’s Decidedly Average Year

Emily BurkeThe WEEKLY

2013 DECIDEDLY AVERAGE FOR THE FDA The FDA approved 27 new drugs in 2013, down from the 15-year high of 2012 with its 39 approvals. This should not be cause for alarm since 2013 numbers fall in line with the average of 28 over the last five years (FDA.gov). The FDA attributes the drop to fewer applications received: 32 for … Read More